Eligo Bioscience

  • Founded in 2014
  • Employees: 15
  • Financial data: €20M Total Raised (as of 12/2017)


Description :

The synthetic biology platform, which combines CRISPR/Cas system with engineered phage capsids,enables the development of “eligobiotics”: a new generation of highly precise antimicrobials

Headquarters :

Eligo Bioscience – 28 rue du Docteur Roux, Centre François Jacob – 75015, Paris

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.